Back

The prognostic impact of fibroblast growth factor-23 on cardiovascular death after cardiac surgery

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Biomarkers ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Felix Hofer

Medical University of Vienna, Vienna (Austria)

224 More presentations in this session

Presentation thumbnail
High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events
Doctor B. Keskin Meric (London, GB)
Abstract Slides
Presentation thumbnail
Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines
Doctor R. Ong (Makati, PH)
Abstract Slides
Presentation thumbnail
Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project
Doctor A. Bendary (Benha, EG)
Abstract Slides
Presentation thumbnail
SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization
Mr R. Gascuena (Leganes, ES)
Abstract Slides
Presentation thumbnail
Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome
Doctor S. Vohra (Lucknow, IN)
Abstract Slides

Access the full session

Session thumbnail
Risk Factors and Prevention ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources